{"id":"W4220978609","doi":"10.1016/j.jaip.2022.02.047","title":"Short-Acting Beta-2-Agonist Exposure and Severe Asthma Exacerbations: SABINA Findings From Europe and North America","year":2022,"lang":"en","type":"article","venue":"The Journal of Allergy and Clinical Immunology In Practice","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Saskatchewan; University of Calgary","funders":"Sanofi Genzyme; Genentech; Covis Pharma; Amgen; Boehringer Ingelheim; AstraZeneca; Chiesi Farmaceutici; Meso Scale Diagnostics; Sanofi; Regeneron Pharmaceuticals; Teva Pharmaceutical Industries; Novartis; GlaxoSmithKline","keywords":"Medicine; Rate ratio; Asthma; Demography; Incidence (geometry); Concomitant; Population; Observational study; Medical prescription; Family medicine; Internal medicine; Pediatrics; Environmental health","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008964812,0.0001211785,0.0003622965,0.00005157847,0.0003759792,0.00002357582,0.0001208434,0.00007438388,0.0000994701],"category_scores_gemma":[0.001515429,0.00008442008,0.00005497452,0.0001525898,0.0004522733,0.000254786,0.000230988,0.001298145,0.000001972003],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001988676,"about_ca_system_score_gemma":0.0001200132,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003764507,"about_ca_topic_score_gemma":0.00002528429,"domain_scores_codex":[0.9977556,0.001102054,0.0006595075,0.0001615519,0.0001710765,0.0001502341],"domain_scores_gemma":[0.9963757,0.002841143,0.0004078503,0.0001608446,0.0001167436,0.00009775501],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0250934,0.002556882,0.5212168,0.00002364987,0.008660584,0.002086759,0.006763308,0.000168632,0.001069131,0.0001823777,0.001559711,0.4306188],"study_design_scores_gemma":[0.001900821,0.003114054,0.8375508,0.00004113236,0.00062768,0.0016685,0.01388353,0.00003487364,0.000004231545,0.00003692534,0.1410213,0.0001162086],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9767633,0.01610316,0.00001807198,0.006476906,0.0001889254,0.00008744014,0.000007576117,0.000006529914,0.0003481115],"genre_scores_gemma":[0.9681424,0.02951953,0.0002534455,0.001845257,0.0001116478,0.000002717654,0.000005589464,0.00001337796,0.0001060132],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4305025,"threshold_uncertainty_score":0.5639868,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02860247901186177,"score_gpt":0.3205655994398333,"score_spread":0.2919631204279716,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}